Toll-like receptor 3-activated macrophages confer anti-HCV activity to hepatocytes through exosomes

FASEB Journal

Volumn 30, Issue 12, 2016, Pages 4132-4140

  Zhou, Yu ^a   Wang, Xu ^b   Sun, Li ^b   Zhou, Li ^b   Ma, Tong Cui ^b   Song, Li ^b   Wu, Jian Guo ^b   Li, Jie Liang ^b   Ho, Wen Zhe ^a,b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WUHAN UNIVERSITY   (China)

Author keywords

Exosomes; Hepatitis C virus; MiRNA

Indexed keywords

MICRORNA 29; POLYINOSINIC POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR 3; TLR3 PROTEIN, HUMAN;

ANTIVIRAL ACTIVITY; ARTICLE; CELL COMMUNICATION; CELL PROTECTION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; EXOSOME; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; INNATE IMMUNITY; LIVER CELL; MACROPHAGE; MACROPHAGE ACTIVATION; MACROPHAGE CULTURE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VIRUS REPLICATION; HEPACIVIRUS; IMMUNOLOGY; LIVER; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE; VIROLOGY;

CELL COMMUNICATION; CELL LINE, TUMOR; EXOSOMES; HEPACIVIRUS; HEPATOCYTES; HUMANS; IMMUNITY, INNATE; LIVER; MACROPHAGES; TOLL-LIKE RECEPTOR 3; VIRUS REPLICATION;

EID: 85002323680     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.201600696R     Document Type: Article

References (46)

1. Park, S. H., and Rehermann, B. (2014) Immune responses to HCV and other hepatitis viruses. Immunity 40, 13-24
2. Battaglia, A. M., and Hagmeyer, K. O. (2000) Combination therapy with interferon and ribavirin in the treatment of chronic hepatitis C infection. Ann. Pharmacother. 34, 487-494
3. Gale, M., Jr., and Foy, E. M. (2005) Evasion of intracellular host defence by hepatitis C virus. Nature 436, 939-945
4. Li, K., Foy, E., Ferreon, J. C., Nakamura, M., Ferreon, A. C., Ikeda, M., Ray, S. C., Gale, M., Jr., and Lemon, S.M. (2005) Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc. Natl. Acad. Sci. USA 102, 2992-2997
5. Foy, E., Li, K., Sumpter, R., Jr., Loo, Y. M., Johnson, C. L., Wang, C., Fish, P. M., Yoneyama, M., Fujita, T., Lemon, S. M., and Gale, M., Jr. (2005) Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. Proc. Natl. Acad. Sci. USA 102, 2986-2991
6. Koziel, M. J. (2005) Cellular immune responses against hepatitis C virus. Clin. Infect. Dis. 41(Suppl 1), S25-S31
7. Heydtmann, M. (2009) Macrophages in hepatitis B and hepatitis C virus infections. J. Virol. 83, 2796-2802
8. Negash, A. A., Ramos, H. J., Crochet, N., Lau, D. T., Doehle, B., Papic, N., Delker, D. A., Jo, J., Bertoletti, A., Hagedorn, C. H., and Gale, M., Jr. (2013) IL-1β production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease. PLoS Pathog. 9, e1003330
9. Revie, D., and Salahuddin, S. Z. (2014) Role of macrophages and monocytes in hepatitis C virus infections. World J. Gastroenterol. 20, 2777-2784
10. Yang, L., and Seki, E. (2012) Toll-like receptors in liver fibrosis: cellular crosstalk and mechanisms. Front. Physiol. 3, 138
11. Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., and Lötvall, J. O. (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novelmechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654-659
12. Théry, C., Zitvogel, L., and Amigorena, S. (2002) Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2, 569-579
13. Joyce, D. P., Kerin, M. J., and Dwyer, R. M. (2016) Exosomeencapsulated microRNAs as circulating biomarkers for breast cancer. Int. J. Cancer 139, 1443-1448
14. VanNiel, G., Wubbolts, R., TenBroeke, T., Buschow, S. I., Ossendorp, F. A., Melief, C. J., Raposo, G., van Balkom, B. W., and Stoorvogel, W. (2006) Dendritic cells regulate exposure of MHC class II at their plasma membrane by oligoubiquitination. Immunity 25, 885-894
15. Federici, C., Petrucci, F., Caimi, S., Cesolini, A., Logozzi, M., Borghi, M., D'Ilio, S., Lugini, L., Violante, N., Azzarito, T., Majorani, C., Brambilla, D., and Fais, S. (2014) Exosome release and lowpHbelong to a framework of resistance of human melanoma cells to cisplatin. PLoS One 9, e88193
16. Parolini, I., Federici, C., Raggi, C., Lugini, L., Palleschi, S., De Milito, A., Coscia, C., Iessi, E., Logozzi, M., Molinari, A., Colone, M., Tatti, M., Sargiacomo, M., and Fais, S. (2009) Microenvironmental pH is a key factor for exosome traffic in tumor cells. J. Biol. Chem. 284, 34211-34222
17. De Toro, J., Herschlik, L., Waldner, C., and Mongini, C. (2015) Emerging roles of exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applications. Front. Immunol. 6, 203
18. Meckes, D. G., Jr., and Raab-Traub, N. (2011) Microvesicles and viral infection. J. Virol. 85, 12844-12854
19. Raposo, G., and Stoorvogel, W. (2013) Extracellular vesicles: exosomes, microvesicles, and friends. J. Cell Biol. 200, 373-383
20. Mittelbrunn, M., Gutiérrez-Vázquez, C., Villarroya-Beltri, C., González, S., Sánchez-Cabo, F., González, M. A., Bernad, A., and Sánchez-Madrid, F. (2011) Unidirectional transfer of microRNAloaded exosomes from T cells to antigen-presenting cells. Nat. Commun. 2, 282
21. Rabinowits, G., Gerçel-Taylor, C., Day, J. M., Taylor, D. D., and Kloecker, G.H. (2009) ExosomalmicroRNA: a diagnosticmarker for lung cancer. Clin. Lung Cancer 10, 42-46
22. Wang, X., Ye, L., Hou, W., Zhou, Y., Wang, Y. J., Metzger, D. S., and Ho, W. Z. (2009) Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection. Blood 113, 671-674
23. Zhou, Y., Wang, X., Liu, M., Hu, Q., Song, L., Ye, L., Zhou, D., and Ho, W. (2010) A critical function of toll-like receptor-3 in the induction of anti-human immunodeficiency virus activities in macrophages. Immunology 131, 40-49
24. Abusamra, A. J., Zhong, Z., Zheng, X., Li, M., Ichim, T. E., Chin, J. L., and Min, W. P. (2005) Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis. Blood Cells Mol. Dis. 35, 169-173
25. Wang, Y., Li, J., Wang, X., Ye, L., Zhou, Y., and Ho, W. (2013) Induction of interferon-λ contributes to Toll-like receptor-3-activated hepatic stellate cell-mediated hepatitis C virus inhibition in hepatocytes. J. Viral Hepat. 20, 385-394
26. Kanda, T., Steele, R., Ray, R., and Ray, R. B. (2007) Hepatitis C virus infection induces the beta interferon signaling pathway in immortalized human hepatocytes. J. Virol. 81, 12375-12381
27. Ye, L., Wang, X., Wang, S., Wang, Y., Song, L., Hou, W., Zhou, L., Li, H., and Ho, W. (2009) CD56+ T cells inhibit hepatitis C virus replication in human hepatocytes. Hepatology 49, 753-762
28. Wang, Y., Li, J., Wang, X., Ye, L., Zhou, Y., Thomas, R. M., and Ho, W. (2014) Hepatitis C virus impairs TLR3 signaling and inhibits IFN-λ 1 expression in human hepatoma cell line. Innate Immun. 20, 3-11
29. Lemon, S. M. (2010) Induction and evasion of innate antiviral responses by hepatitis C virus. J. Biol. Chem. 285, 22741-22747
30. Kaukinen, P., Sillanpää, M., Kotenko, S., Lin, R., Hiscott, J., Melén, K., and Julkunen, I. (2006) Hepatitis C virus NS2 and NS3/4A proteins are potent inhibitors of host cell cytokine/chemokine gene expression. Virol. J. 3, 66
31. Horner, S.M., Park, H. S., and Gale, M., Jr. (2012) Control of innate immune signaling and membrane targeting by the Hepatitis C virus NS3/4A protease are governed by the NS3 helix α0. J. Virol. 86, 3112-3120
32. Sampey, G. C., Meyering, S. S., Asad Zadeh, M., Saifuddin, M., Hakami, R.M., and Kashanchi, F. (2014) Exosomes and their role in CNS viral infections. J. Neurovirol. 20, 199-208
33. Buschow, S. I., van Balkom, B. W., Aalberts, M., Heck, A. J., Wauben, M., and Stoorvogel, W. (2010) MHC class II-associated proteins in Bcell exosomes and potential functional implications for exosome biogenesis. Immunol. Cell Biol. 88, 851-856
34. Fang, Y., Wu, N., Gan, X., Yan, W., Morrell, J. C., and Gould, S. J. (2007) Higher-order oligomerization targets plasma membrane proteins and HIV gag to exosomes. PLoS Biol. 5, e158
35. Jaworski, E., Narayanan, A., Van Duyne, R., Shabbeer-Meyering, S., Iordanskiy, S., Saifuddin, M., Das, R., Afonso, P. V., Sampey, G. C., Chung, M., Popratiloff, A., Shrestha, B., Sehgal, M., Jain, P., Vertes, A., Mahieux, R., and Kashanchi, F. (2014) Human T-lymphotropic virus type 1-infected cells secrete exosomes that containTax protein. J. Biol. Chem. 289, 22284-22305
36. Jaworski, E., Saifuddin, M., Sampey, G., Shafagati, N., Van Duyne, R., Iordanskiy, S., Kehn-Hall, K., Liotta, L., Petricoin III, E., Young, M., Lepene, B., and Kashanchi, F. (2014) The use of Nanotrap particles technology incapturing HIV-1 virions andviral proteins frominfected cells. PLoS One 9, e96778
37. Zhu, X., He, Z., Yuan, J., Wen, W., Huang, X., Hu, Y., Lin, C., Pan, J., Li, R., Deng, H., Liao, S., Zhou, R., Wu, J., Li, J., and Li, M. (2015) IFITM3-containing exosome as a novel mediator for anti-viral response in dengue virus infection. Cell. Microbiol. 17, 105-118
38. Stone, L. (2016) Kidney cancer: exosome transmission of sunitinib resistance. Nat. Rev. Urol. 13, 297
39. Stone, L. (2016) Prostate cancer: exosome RNA expression predicts high-grade disease. Nat. Rev. Urol. 13, 298-299
40. Gibbings, D. J., Ciaudo, C., Erhardt, M., and Voinnet, O. (2009) Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat. Cell Biol. 11, 1143-1149
41. Hu, G., Drescher, K.M., and Chen, X.M. (2012) Exosomal miRNAs: biological properties and therapeutic potential. Front. Genet. 3, 56
42. Schorey, J. S., and Bhatnagar, S. (2008) Exosome function: from tumor immunology to pathogen biology. Traffic 9, 871-881
43. Bandyopadhyay, S., Friedman, R. C., Marquez, R.T., Keck, K., Kong, B., Icardi, M. S., Brown, K. E., Burge, C. B., Schmidt, W. N., Wang, Y., and McCaffrey, A. P. (2011) Hepatitis C virus infection and hepatic stellate cell activation downregulate miR-29: miR-29 overexpression reduces hepatitis C viral abundance in culture. J. Infect. Dis. 203, 1753-1762
44. Sulkowski, M. S., Moore, R. D., Mehta, S. H., Chaisson, R. E., and Thomas, D. L. (2002) Hepatitis C and progression of HIV disease. JAMA 288, 199-206
45. Hoffmann, T. W., Duverlie, G., and Bengrine, A. (2012) MicroRNAs and hepatitis C virus: toward the end of miR-122 supremacy. Virol. J. 9, 109
46. Wang, Y., Li, J., Wang, X., Zhou, Y., Zhang, T., and Ho, W. (2015) HCV dsRNA-activated macrophages inhibit HCV replication in hepatocytes. Hepat. Mon. 15, e29282